Header Logo

Connection

CARLA DAVIS to Omalizumab

Back to Details
This is a "connection" page, showing publications CARLA DAVIS has written about Omalizumab.
CARLA DAVIS
Connection Strength
0.045
Omalizumab
  1. Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation. Contemp Clin Trials. 2021 01; 100:106228.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.